期刊文献+

双联抗血小板药物治疗急性脑梗死发生颅内出血的危险因素分析 被引量:6

Analysis of risk factors of intracerebral hemorrhagic complications in the treatment of acute cerebral infarc- tion with dual antiplatelet drugs
原文传递
导出
摘要 目的:观察双联抗血小板治疗急性脑梗死引起颅脑出血的危险因素。方法选择急性脑梗死患者1806例,口服阿司匹林100 mg、氯吡格雷75 mg治疗2~3周,通过颅脑CT和MRI扫描确诊出并发颅脑出血的患者,采用χ^2检验和Logistic回归分析各危险因素与颅脑出血的关系。结果年龄≥65岁、高血压病、血糖≥8 mmol/L ,NIHSS评分≥10分、早期CT出现低密度征、大脑中动脉高密度征是并发颅脑出血的危险因素。结论双联抗血小板治疗急性脑梗死应避免上述危险因素的叠加,以降低并发颅脑出血的发生几率。
出处 《神经疾病与精神卫生》 2015年第3期271-273,共3页 Journal of Neuroscience and Mental Health
基金 基金项目:河北省卫生厅课题(20130613)
关键词 急性脑梗死 氯吡格雷 阿司匹林 颅内出血 Acute cerebral infarction Clopidogrel Aspirin Intracerebral haemorrhage
  • 相关文献

参考文献8

  • 1Kennedy J, Hill MD, Ryckborst KJ, et al. Eliasziw M Fast as- sessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER) : a randomised controlled pilot trial [J]. Lancet Neurol,2007,6(11) :961-969.
  • 2Geeganage CM, Diener HC, Algra A, et al. Dual or Mono An- tiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemie Attack Systematic Review and Meta-Anal- ysis of Randomized Controlled Trials[J]. Stroke, 2012,43 (4) : 1 058-1 066.
  • 3贾建平,江汉秋.老年脑出血的临床研究进展[J].实用老年医学,2007,21(4):220-222. 被引量:8
  • 4李东瑞,杨伟民,苏楠,滕军放.脑梗死后出血转化危险因素分析[J].中国实用神经疾病杂志,2013,16(10):102-104. 被引量:9
  • 5郭文超,潘速跃.急性脑梗死后出血转化的临床特征研究[J].重庆医学,2013,42(31):3781-3783. 被引量:12
  • 6盛文利,黄如训.重视脑梗死的出血性转化[J].中国神经精神疾病杂志,2012,38(2):126-128. 被引量:26
  • 7Kruyt ND, Biessels GJ, Devries JH, et al. Hyperglycemia in a- cute ischemic stroke: pathophysiology and clinical management [J]. Nat Rev Neurol,2010,6(3):145-155.
  • 8Mishiro K, Imai T, Sugitani S, eta|. Diabetes mellitus aggra- vates hemorrhagic transformation after ischemic stroke via mito- chondrial defects leading to endothelial apoptosis[J]. PLoS One,2014,9(8) : e103 818.

二级参考文献46

  • 1杨永利.大面积脑梗死46例临床分析[J].第四军医大学学报,2005,26(B12):57-57. 被引量:12
  • 2张祥建,李春岩.出血性脑梗死[J].实用心脑肺血管病杂志,2006,14(4):265-266. 被引量:8
  • 3秦俭(编译),赵妍(编译).胆固醇水平与出血性脑卒中发病的人群差别:血清胆固醇与出血性脑卒中、缺血性脑卒中及心肌梗死:韩国国家卫生系统前瞻性队列研究[J].世界急危重病医学杂志,2006,3(4):1397-1400. 被引量:43
  • 4Mohr JP,Wolf PA,Grotta JC,et al.Stroke:pathophysiology,diagnosis,and management[M].Fifth Edition.Elsevier,2011,293-306.
  • 5The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute is-chemic stroke[J].N Engl J Med,1995,333(24):1581-1587.
  • 6The NINDS t-PA Stroke Study Group.Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke[J].Stroke,1997,28(ll):2109-2118.
  • 7Connolly SJ,Ezekowitz MD,Yusuf S,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med 2009,361(12):1139-1151.
  • 8Costalat V,Machi P,Lobotesis K,et al.Rescue,combined,and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device:a prospective 50-pa-tient single-center study[J].Stroke,2011,42(7):1929-1935.
  • 9Kumar:Robbins and Cotran Pathologic Basis of Disease,Professional Edition,8th ed.2009,W.B.Saunders,An imprint of Elsevier,Chapter 4-Hemodynamic Disorders,Thromboembolic Disease,and Shock.Chapter 28-The Central Nervous System.
  • 10Lodder J,Krune-Kubat B,Broekman J.Cerebral hemorrhagic infarction at autopsy:cardiac embolic cause and the relationship to the cause of death[J].Stroke,1986,17(4):626-629.

共引文献49

同被引文献44

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部